Total number of patients (%) |
101 (100) |
67 (66.3) |
34 (33.7) |
|
STEMI, no (%) |
91 (90.1) |
58 (57.4) |
33 (32.7) |
0.158 |
MI territory |
Anterior, no (%) |
61 (61.0) |
42 (42.0) |
19 (19.0) |
0.667 |
Inferior, no (%) |
38 (38.0) |
26 (26.0) |
12 (12.0) |
1.000 |
Lateral, no (%) |
32 (32.0) |
22 (22.0) |
10 (10.0) |
1.000 |
RV involvement, no (%) |
5 (5.0) |
1 (1.0) |
4 (4.0) |
0.040 |
Peak troponin, ng/L med (IQR) |
38.9 (13.7–40.0) |
26.8 (10.9–40.0) |
40.0 (19.1–626.0) |
0.146 |
LV systolic function |
Normal, no (%) |
10 (11.6) |
8 (9.3) |
2 (2.3) |
0.488 |
Mild dysfunction, no (%) |
26 (30.2) |
21 (24.4) |
5 (5.8) |
0.093 |
Moderate dysfunction, no (%) |
22 (25.6) |
17 (19.8) |
5 (5.8) |
0.309 |
Severe dysfunction, no (%) |
28 (32.6) |
14 (16.3) |
14 (16.3) |
0.037 |
Thrombolysis pre-PPCI, no (%) |
1 (1.0) |
1 (1.0) |
0 (0.0) |
1.000 |
Angiogram, (successful completion) no (%) |
99 (98.0) |
67 (66.3) |
32 (31.7) |
0.111 |
PCI performed (successful completion), no (%) |
91 (90.1) |
62 (61.4) |
29 (28.7) |
0.298 |
IABP in cath lab, no (%) |
50 (49.5) |
28 (27.7) |
22 (21.8) |
0.036 |
Number of diseased vessels, med (IQR) |
2 (1–3) |
2 (1–3) |
2 (2–3) |
0.514 |
Left main stem disease, no (%) |
14 (14.1) |
8 (8.1) |
6 (6.1) |
0.371 |
TIMI flow, med (IQR) |
3 (2–3) |
3 (2–3) |
3 (2–3) |
0.862 |
Symptom onset to device time (min, med (IQR) |
210 (155–332) |
219 (159–328) |
200 (150–350) |
0.665 |